Tetraphase (NASDAQ: TTPH) is a biopharmaceutical company using its proprietary chemistry technology to create novel antibiotics for serious and life-threatening bacterial infections; its lead product XERAVATM (eravacycline) is approved for the treatment of complicated intra-abdominal infections by the FDA and EMA. Learn more at www.tphase.com.
Threat Stack enables growth-driven companies to scale securely and meet complex cloud security needs by identifying and verifying insider threats, external attacks, and data loss in real time. With a comprehensive approach to intrusion detection, Threat Stack empowers security and operations to better manage risk and compliance across their entire infrastructure, including cloud, hybrid cloud, multi-cloud, and containerized environments. Learn more at www.threatstack.com.
Launched in 2013, Toast powers successful restaurants of all sizes with a technology platform that combines restaurant POS, front of house, back of house and guest-facing technology with a diverse marketplace of third-party applications. By pairing technology with an unrivaled commitment to customer success, Toast helps restaurants streamline operations, increase revenue and deliver amazing guest experiences. Toast was named to the 2018 Forbes Cloud 100 and recognized as the third fastest-growing technology company in North America on the 2017 Deloitte Fast 500. Learn more at www.toasttab.com.
TraceLink the world’s largest Track and Trace Network for connecting the life sciences supply chain and providing real-time information sharing for better patient outcomes. Learn more at www.tracelink.com.
Tradier is an API-driven online broker dealer, providing independent software developers with the ability to easily embed trading and market data into their applications. Learn more at www.tradier.com.
Ultragenyx (NASDAQ: RARE) a biopharmaceutical company committed to bringing to patients novel products for the treatment of serious rare and ultra-rare genetic diseases. Learn more at www.ultragenyx.com.
Unbxd applies artificial intelligence and advanced data sciences to connect e-commerce shoppers to the products they are most likely to buy. Learn more at www.unbxd.com.
Mountain View, CA
Unison is the leading provider of home ownership investments, modernizing home financing through long-term partnerships. Unison works with lenders, regulators and institutional investors to integrate home ownership investing into the U.S. housing finance system. Unison HomeBuyer helps purchasers buy the home they want with less debt and risk, typically by doubling the down payment. The larger down payment makes it easier to qualify for a loan, increases buying power, lowers the monthly payment and/or allows a buyer to reserve cash. Unison HomeOwner provides current homeowners with cash to eliminate debt, remodel, pay for school, invest or use as a cash cushion, without the added debt or payments of a home equity loan or HELOC. Learn more at www.unison.com.
Valor Performance is the premier digital learning platform focused on sustaining performance for executives and sales leaders. Valor’s software platform delivers personalized and research-based exercises as well as dedicated Valor coaches, who integrate the latest research on stress management and burnout with the insights of world-class athletes. Learn more at www.valorperform.com.
Verid developed a knowledge-based authentication platform helping businesses to authenticate consumers through a series of questions. Verid was acquired by EMC in 2007.
Ft. Lauderdale, FL
Verve Therapeutics is a biotechnology company created with a singular focus: to protect the world from heart disease. Verve is developing therapies to safely edit the genome of adults and confer lifelong protection from coronary artery disease, the most common form of heart disease and the leading cause of death worldwide. Learn more at www.vervetx.com.
Vestwell is a digital platform that makes it easier to offer and administer 401(k) plans. Vestwell removes traditional friction points through a seamless plan design, automated onboarding, streamlined administration, and flexible investment strategies, all at competitive pricing. By acting as a single point of contact, Vestwell has modernized the retirement offering while keeping the plan sponsor’s and plan participant’s best interests in mind. Learn more at www.vestwell.com.
Vicept Therapeutics is a dermatology specialty pharmaceutical company developing a topical prescription product for the treatment of the chronic skin condition, Rosacea. Vicept Therapeutics was acquired by Allergan.
ViewRay (NASDAQ: VRAY) designs, manufactures and markets the MRIdian® radiation therapy system. Which uses a high-definition MR imaging system designed from the ground up to address the unique challenges and clinical workflow for advanced radiation oncology. Learn more at www.viewray.com.
VitalWare makes the business of healthcare easier for providers through cloud-based SaaS solutions for analytics, documentation, coding, billing, and auditing technologies. VitalWare was acquired by Health Catalyst in 2020.
Wellframe is a Boston-based digital medicine company focused on building the next generation of infrastructure for clinical care delivery by combining artificial intelligence, medicine, and large scale computer systems. Learn more at www.wellframe.com.
Whatfix is a leading digital guidance and engagement platform that helps companies provide intuitive onboarding, and effective training and support. Whatfix’s contextual and personalized in-app content drives-up user productivity and engagement. Learn more at whatfix.com.
Xilio Therapeutics is a biotechnology company advancing next-generation cancer immunotherapies designed to improve patient outcomes by unleashing the power of the immune system selectively at the site of the tumor. Learn more at www.xiliotx.com.
Xoom is a digital money transfer company that allows users to securely transfer money online. Xoom went public in 2013 and was then acquired by PayPal in 2015. Learn more at www.xoom.com.
San Francisco, CA
YishengBio Co., Ltd. is a global, fully integrated biopharmaceutical company headquartered in Beijing. The Company is engaged in discovering, developing and commercializing innovative vaccines and biotherapeutics for cancers and infectious diseases using the novel PIKA® immunomodulating technology. Learn more at www.yishengbio.com.